Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Stomach Neoplasms 3Neoplasms 3Colorectal Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Peritoneal Neoplasms 1Ornithine Carbamoyltransferase Deficiency Disease 1Obesity, Morbid 1Neurologic Manifestations 1Melanoma 1Lung Neoplasms 1Liver Neoplasms 1Gynecological Cancer 1Genital Diseases, Female 1Endometrial Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Merkel Cell 1Brain Neoplasms 1

Interventions

Bevacizumab 9pembrolizumab 5lenvatinib 5durvalumab 5atezolizumab 5tremelimumab 3fludarabine 3camrelizumab 3apatinib 3Ipilimumab 3Cyclophosphamide 3regorafenib 2Riluzole 2Radiotherapy 2Nivolumab 2Magnetic Resonance Imaging 2Idarubicin 2Blood Specimen Collection 2Biopsy 2yttrium chloride 1trastuzumab deruxtecan 1spartalizumab 1sintilimab 1pertuzumab 1ferric carboxymaltose 1epigallocatechin gallate 1donafenib 1cemiplimab 1brodalumab 1Yttrium-90 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Liver Neoplasms × Laparoscopy × Clear all
NCT06753136 2026-04-13

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Istituto Oncologico Veneto IRCCS

Phase NA Recruiting
24 enrolled
DermatologicGastrointestinal

Carcinoma, Squamous Cell, Liver Neoplasms, Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡